These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 24951861)
1. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection. Trentini MM; de Oliveira FM; Gaeti MP; Batista AC; Lima EM; Kipnis A; Junqueira-Kipnis AP Vaccine; 2014 Jul; 32(34):4324-32. PubMed ID: 24951861 [TBL] [Abstract][Full Text] [Related]
2. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
4. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants. Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499 [TBL] [Abstract][Full Text] [Related]
5. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice. Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108 [TBL] [Abstract][Full Text] [Related]
7. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175 [TBL] [Abstract][Full Text] [Related]
8. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis. Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525 [TBL] [Abstract][Full Text] [Related]
9. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection. Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine. Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein. Deng YH; He HY; Zhang FJ Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772 [TBL] [Abstract][Full Text] [Related]
12. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant. Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445 [TBL] [Abstract][Full Text] [Related]
13. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736 [TBL] [Abstract][Full Text] [Related]
14. Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis. Szachniewicz MM; van den Eeden SJF; van Meijgaarden KE; Franken KLMC; van Veen S; Geluk A; Bouwstra JA; Ottenhoff THM Eur J Pharm Biopharm; 2024 Oct; 203():114437. PubMed ID: 39122053 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC). Lew MH; Norazmi MN; Tye GJ Mol Immunol; 2020 Jan; 117():54-64. PubMed ID: 31739193 [TBL] [Abstract][Full Text] [Related]
16. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice. Kim A; Hur YG; Gu S; Cho SN Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927 [TBL] [Abstract][Full Text] [Related]
17. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366 [TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090 [TBL] [Abstract][Full Text] [Related]
19. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584 [TBL] [Abstract][Full Text] [Related]
20. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency. Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]